Ann: Study shows efficacy of ResAppDx use with masks, page-8

The gutz of the announcement is in the first paragraph.

Study shows efficacy of ResAppDx use with masks
Brisbane, Australia, 22 July 2022 – ResApp Health Limited (ASX:RAP), a leading digital health
company developing smartphone applications for the diagnosis and management of respiratory
disease, is pleased to announce the results of a small clinical study which investigated the use of
ResAppDx to identify acute respiratory disease in patients wearing surgical masks. The study
showed substantial or near perfect agreement between patients wearing a mask and not wearing
a mask for all studied endpoints.

I say its quite an important announcement. Some critics might have asked how well the ResappDX app would work in an environment requiring masks to be worn. Now we know. Masks don't affect its operation!.